INS and liver cancer: Observational studies from different countries and areas support the belief that the use of antidiabetic drugs which increase insulin sensitivity, such as metformin or thiazolidinediones (TZDs), may decrease the incidence of liver cancer, while exposure to insulin and sulphonylurea has been associated with an excess HCC risk14, 15, 16.